Journal of Andrology, Vol 22, Issue 4 672-679, Copyright © 2001 by The American Society of Andrology

JOURNAL ARTICLE

Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process

E. de Lamirande, K. Yoshida, T. M. Yoshiike, T. Iwamoto and C. Gagnon
Urology Research Laboratory, Royal Victoria Hospital and McGill University, Montreal, Quebec, Canada. edelamirande@hotmail.com

Semenogelin (Sg), the major protein of the human semen coagulum, is present at high concentrations in seminal vesicle secretions. It is degraded by the prostate-specific antigen (PSA) to generate peptides of various biological activities that were found on and inside spermatozoa. Our aim was to determine the effect of Sg on capacitation, which is the series of transformations that spermatozoa must undergo to become fertile. At concentrations of 0.1 to 1.0 mg/mL (600- to 20-fold lower than those of semen), Sg did not affect sperm motility (%) but completely prevented capacitation induced by fetal cord serum ultrafiltrate; a partial inhibition of capacitation was noted with 0.03 mg Sg/mL. There was also a dose-dependent decrease in the tyrosine phosphorylation of fibrous sheath proteins and in the O2-.-related chemiluminescence. Ribonuclease (RNase), which has as high an isoelectric point (pI = 9.7) as Sg (pI = 9.5), also prevented sperm capacitation and O2-.-related chemiluminescence but to a lower extent, suggesting that one mechanism of Sg action on spermatozoa could be related to its positive charge at physiological pH. Sg at 1, but not 0.3 or 0.1 mg/mL, scavenged the O2-. generated by the mix of xanthine + xanthine oxidase and modified the kinetics of the reaction; RNase did not have such effects. Therefore, Sg is a potential scavenger for O2-. but probably also affects the sperm oxidase. Spermatozoa rapidly processed Sg; a high proportion of Sg was degraded after 15 minutes of incubation. The resulting polypeptide patterns were reminiscent of those obtained with PSA as a proteolytic enzyme. These data suggest that Sg, its degradation products, or both may be natural regulators of sperm capacitation and could prevent this process from occurring prematurely. One mechanism by which Sg acts could involve an interference with the O2-. that is normally generated during this process.

This article has been cited by other articles:

				A. M. L. Edstrom, J. Malm, B. Frohm, J. A. Martellini, A. Giwercman, M. Morgelin, A. M. Cole, and O. E. Sorensen The Major Bactericidal Activity of Human Seminal Plasma Is Zinc-Dependent and Derived from Fragmentation of the Semenogelins J. Immunol., September 1, 2008; 181(5): 3413 - 3421. [Abstract] [Full Text] [PDF]

				J. L. Mueller, J. R. Linklater, K. Ravi Ram, T. Chapman, and M. F. Wolfner Targeted Gene Deletion and Phenotypic Analysis of the Drosophila melanogaster Seminal Fluid Protease Inhibitor Acp62F Genetics, March 1, 2008; 178(3): 1605 - 1614. [Abstract] [Full Text] [PDF]

				C. L Pin, C. L Johnson, B. Rade, A. S Kowalik, V. C Garside, and M. E Everest Identification of a Transcription Factor, BHLHB8, Involved in Mouse Seminal Vesicle Epithelium Differentiation and Function Biol Reprod, January 1, 2008; 78(1): 91 - 100. [Abstract] [Full Text] [PDF]

				Z. Wang, E. E Widgren, R. T Richardson, and M. G O'Rand Characterization of an Eppin Protein Complex from Human Semen and Spermatozoa Biol Reprod, September 1, 2007; 77(3): 476 - 484. [Abstract] [Full Text] [PDF]

				N. Kawano and M. Yoshida Semen-Coagulating Protein, SVS2, in Mouse Seminal Plasma Controls Sperm Fertility Biol Reprod, March 1, 2007; 76(3): 353 - 361. [Abstract] [Full Text] [PDF]

				Z. Wang, E.E. Widgren, P. Sivashanmugam, M.G. O'Rand, and R.T. Richardson Association of Eppin with Semenogelin on Human Spermatozoa Biol Reprod, May 1, 2005; 72(5): 1064 - 1070. [Abstract] [Full Text] [PDF]

				S. Weidinger, A. Mayerhofer, L. Kunz, M. Albrecht, M. Sbornik, E. Wunn, R. Hollweck, J. Ring, and F.M. Kohn Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway Hum. Reprod., February 1, 2005; 20(2): 456 - 461. [Abstract] [Full Text] [PDF]

				R. J. Aitken, M. A. Baker, and M. O'Bryan Shedding Light on Chemiluminescence: The Application of Chemiluminescence in Diagnostic Andrology J Androl, July 1, 2004; 25(4): 455 - 465. [Full Text] [PDF]

				F. Bourgeon, B. Evrard, M. Brillard-Bourdet, D. Colleu, B. Jegou, and C. Pineau Involvement of Semenogelin-Derived Peptides in the Antibacterial Activity of Human Seminal Plasma Biol Reprod, March 1, 2004; 70(3): 768 - 774. [Abstract] [Full Text] [PDF]

				A. Lundwall, A. Giwercman, Y. Ruhayel, Y. Giwercman, H. Lilja, C. Hallden, and J. Malm A frequent allele codes for a truncated variant of semenogelin I, the major protein component of human semen coagulum Mol. Hum. Reprod., June 1, 2003; 9(6): 345 - 350. [Abstract] [Full Text] [PDF]

				A. Lundwall, A. Bjartell, A.Y. Olsson, and J. Malm Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues Mol. Hum. Reprod., September 1, 2002; 8(9): 805 - 810. [Abstract] [Full Text] [PDF]